WNM device may help decrease ACL injury risk in female soccer athletes

NewsGuard 100/100 Score

Using a wearable neuromuscular device can reduce the risk of ACL injury in female soccer athletes, according to new research presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in Colorado Springs, CO. The study showed functional improvements in athletes who used the devices in combination with a regular training program.

"Our study showed that training with a wearable neuromuscular (WNM) device improved postural control in athletes, without limiting performance," said Michael John Decker, PhD, from the University of Denver in Denver, Colorado. "Moreover, no athletes in the study experienced an ACL injury during training or over the course of the following season."

A total of 79 elite youth and collegiate female soccer players (age 12-25) in the study trained with a WNM device that applied bi-lateral, topical pressure to the medial quadriceps and hamstring muscles. The athletes performed 7 to 9 weeks of pre-season training with the device consisting of strength and conditioning exercises and on-field team practices.

"Research has shown female soccer players have a three times greater risk of ACL injury compared to males, yet only a small portion of soccer coaches are currently utilizing ACL injury risk reduction programs," commented Decker. "We hope these devices offer coaches a practical means to overcome participation barriers, opening the door for more organizations and teams to implement similar programs."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses